Home > Aisling Capital and Merlin Nexus acquire a stake in Bioenvision, Inc.
Stake Purchase · Life Science

Aisling Capital and Merlin Nexus acquire a stake in Bioenvision, Inc.

Aisling Capital and Merlin Nexus acquired a stake in Bioenvision, Inc., a life science company in New York, United States.

Deal at a glance

TypeStake Purchase TargetBioenvision, Inc. Buyers Aisling Capital
Merlin Nexus
SectorLife Science LocationNew York, United States ValueNot disclosed

Target company

Bioenvision, Inc.
New York, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyers (2)

Private equity firm · 88 deals on record
Merlin Nexus Co-investor
Private equity firm · 29 deals on record
88deals, all time
65in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Ollin Biosciences, Inc.Same sector and country · Nov 2026
OmnioseSame sector and country · Nov 2026
Mithril MedicineSame sector and country · Oct 2026

Questions about this deal

Who acquired Bioenvision, Inc.?Aisling Capital and Merlin Nexus acquired a stake in Bioenvision, Inc..

What type of deal was it?It was a stake purchase in the life science sector.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).